Chemours
430 hedge funds and large institutions have $1.71B invested in Chemours in 2025 Q2 according to their latest regulatory filings, with 80 funds opening new positions, 157 increasing their positions, 90 reducing their positions, and 58 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
430
Holders Change
+16
Holders Change %
+3.86%
% of All Funds
5.76%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.07%
New
80
Increased
157
Reduced
90
Closed
58
Calls
$25.1M
Puts
$18.1M
Net Calls
+$7.02M
Net Calls Change
+$5.29M
Top Buyers
| 1 |
BlackRock
New York
|
+$49.3M |
| 2 |
Millennium Management
New York
|
+$38.8M |
| 3 |
SCM
Scopia Capital Management
New York
|
+$16M |
| 4 |
AWAM
Appian Way Asset Management
New York
|
+$15.4M |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$13.6M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$123M |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$39.5M |
| 3 |
JPMorgan Chase & Co
New York
|
-$24.6M |
| 4 |
KCM
Khrom Capital Management
Miami Beach,
Florida
|
-$19.3M |
| 5 |
LSV Asset Management
Chicago,
Illinois
|
-$13.5M |
